AXON Neuroscience
Cyprus - LarnacaBiotechnology
Focus: AXON Neuroscience is a specialized biotech company focused on tau-targeted vaccines for neurodegenerative diseases, particularly Alzheimer's. The company operates at a mid-cap scale with 51-200 employees and is publicly traded.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
0
About AXON Neuroscience
AI assessmentNot HiringNo open roles listed right now. Follow AXON Neuroscience to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Aerobic Exercise
Brain ConcussionClinical Trials (1)
NCT05498038Exercise Reset for Concussion in a Military Environment
N/AHelp build intelligence for AXON Neuroscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.